Faster post-COVID-19 recovery is observed after infection with the Omicron vs earlier variants, regardless of vaccination status.

The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® ( RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...

Alone and in combination with other lower respiratory tract disease signs and symptoms, dyspnea is the best predictor of severe RSV outcomes.

Researchers have found that patients with high consumption of ultra-processed food have increased risk for hypertension.

Nonadherence to cancer screening varies by screening type and sex, according to study findings published in JAMA Network Open.

Tamara Dörr, M.D., from the Cantonal Hospital St. Gallen in Switzerland, and colleagues assessed the burden and course of PASC in health care workers during a 30-month period. The analysis included ...

Disability is a significant risk factor for lower QOL and increased caregiver burden among children with epilepsy and their caregivers.

Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist.

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

Health care spending in the United States reached $4.9 trillion and increased 7.5% in 2023, according to study findings.

One in four older US veterans report being diagnosed with cardiovascular disease in their lifetime, according to study findings.